Skip to main content

Advertisement

Log in

Prediction of Indolent Breast Cancer with Favorable Prognostic Factors by Metabolic Profiling Using In Vivo and Ex Vivo MR Metabolomics

  • Published:
Applied Magnetic Resonance Aims and scope Submit manuscript

Abstract

To evaluate whether metabolic profiles obtained using high-resolution magic angle spinning magnetic resonance spectroscopy (HR MAS MRS) and total choline-containing compound (tCho) on in vivo MRS could predict indolent tumors based on highly favorable prognostic factors. We analyzed 50 frozen tissue samples from 50 patients (mean 46.4 years, range 29–72 years) with breast cancer using HR MAS MRS. In vivo single-voxel MRS analyses were also performed on these patients preoperatively. We defined estrogen receptor (ER)-positive tumors with a low histological grade, low Ki-67-positivity (<14 %), and negative lymph node metastases as an indolent tumor. By univariate analysis, metabolic profiles on HR MAS MRS and tCho on in vivo MRS were compared according to dichotomized pathological parameters using the Mann–Whitney test. By multivariate analysis, orthogonal projections to latent structure-discriminant analysis (OPLS-DA) were performed to differentiate groups with different prognostic pathological parameters. A total of 6 indolent tumors (12 %) and 44 non-indolent tumors (88 %) were studied. By univariate analysis, tumors without recurrence showed significantly higher Tau and Cr values than those with recurrence (P = 0.041, respectively). By multivariate analysis, an OPLS-DA model showed sensitivities of 100, 77, and 82 % and specificities of 68, 100, and 96 % for the prediction of indolent tumors, tumors with recurrence, and tumors with lymph node metastases, respectively. By univariate analysis of in vivo MRS, tumors without recurrence showed significantly higher values of tCho than those with recurrence (P = 0.043 and 0.035). Several metabolites of Gly, Lac, Tau, Cr, GPC, and Cho on HR MAS MRS could be potential candidate biomarkers for predicting indolent tumors, tumors with early recurrence, and lymph node metastases. Metabolite profiling using HR MAS MRS might enable the prediction of breast cancer prognoses, especially for ER-positive tumors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. C.M. Perou, A.L. Børresen-Dale, Cold Spring Harb. Perspect. Biol. (2011). doi:10.1101/cshperspect.a003293

    Google Scholar 

  2. J. Ferlay, D.M. Parkin, E. Steliarova-Foucher, Eur. J. Cancer 46, 765–781 (2010)

    Article  Google Scholar 

  3. D. Hanahan, R.A. Weinberg, Cell 144, 646–674 (2011)

    Article  Google Scholar 

  4. G.F. Giskeødegård, S. Lundgren, B. Sitter, H.E. Fjøsne, G. Postma, L.M. Buydens, I.S. Gribbestad, T.F. Bathen, NMR Biomed. 25, 1271–1279 (2012)

    Article  Google Scholar 

  5. S. Moestue, B. Sitter, T.F. Bathen, M.B. Tessem, I.S. Gribbestad, Curr. Top. Med. Chem. 11, 2–26 (2011)

    Article  Google Scholar 

  6. P.J. Bolan, M.T. Nelson, D. Yee, M. Garwood, Breast Cancer Res. 7, 149–152 (2005)

    Article  Google Scholar 

  7. J.S. Choi, H.M. Baek, S. Kim, M.J. Kim, J.H. Youk, H.J. Moon, E.K. Kim, Y.K. Nam, PLoS One 8, e83866 (2013). doi:10.1371/journal.pone.0083866

    Article  ADS  Google Scholar 

  8. B. Sitter, U. Sonnewald, M. Spraul, H.E. Fjösne, I.S. Gribbestad, NMR Biomed. 15, 327–337 (2002)

    Article  Google Scholar 

  9. B. Sitter, S. Lundgren, T.F. Bathen, J. Halgunset, H.E. Fjosne, I.S. Gribbestad, NMR Biomed. 19, 30–40 (2006)

    Article  Google Scholar 

  10. T.F. Bathen, B. Sitter, T.E. Sjøbakk, M.B. Tessem, I.S. Gribbestad, Cancer Res. 70, 6692–6696 (2010)

    Article  Google Scholar 

  11. G.F. Giskeødegård, M.T. Grinde, B. Sitter, D.E. Axelson, S. Lundgren, H.E. Fjøsne, S. Dahl, I.S. Gribbestad, T.F. Bathen, J. Proteome Res. 9, 972–979 (2010)

    Article  Google Scholar 

  12. I.S. Gribbestad, T.E. Singstad, G. Nilsen, H.E. Fjøsne, T. Engan, O.A. Haugen, P.A. Rinck, J. Magn. Reson. Imaging 8, 1191–1197 (1998)

    Article  Google Scholar 

  13. L. Bartella, E.A. Morris, D.D. Dershaw, L. Liberman, S.B. Thakur, C. Moskowitz, J. Guido, W. Huang, Radiology 239, 686–692 (2006)

    Article  Google Scholar 

  14. P.A. Baltzer, M. Dietzel, Radiology 267, 735–746 (2013)

    Article  Google Scholar 

  15. D.K. Yeung, W.T. Yang, G.M. Tse, Radiology 225, 190–197 (2002)

    Article  Google Scholar 

  16. H.J. Shin, H.M. Baek, J.H. Cha, H.H. Kim, AJR Am. J. Roentgenol. 198, W488–W497 (2012)

    Article  Google Scholar 

  17. E. Montagna, V. Bagnardi, N. Rotmensz, G. Viale, G. Cancello, M. Mazza, A. Cardillo, R. Ghisini, V. Galimberti, P. Veronesi, S. Monti, A. Luini, P.R. Raviele, M.G. Mastropasqua, A. Goldhirsch, M. Colleoni, Breast Cancer Res. Treat. 129, 867–875 (2011)

    Article  Google Scholar 

  18. J.J. de Ronde, J. Hannemann, H. Halfwerk, L. Mulder, M.E. Straver, M.K. Vrancken Peeters, J. Wesseling, M. van de Vijver, L.F. Wessels, S. Rodenhuis, Breast Cancer Res. Treat. 119, 119–126 (2010)

    Article  Google Scholar 

  19. M.C. Cheang, S.K. Chia, D. Voduc, D. Gao, S. Leung, J. Snider, M. Watson, S. Davies, P.S. Bernard, J.S. Parker, C.M. Perou, M.K. Ellis, T.O. Nielsen, Breast Cancer Inst. 101, 736–750 (2009)

    Article  Google Scholar 

  20. A. Goldhirsch, W.C. Wood, A.S. Coates, R.D. Gelber, B. Thurlimann, H.J. Senn; Panel members, Ann. Oncol. 22, 1736–1747 (2011)

    Article  Google Scholar 

  21. J.A. Sparano, S. Paik, J. Clin. Oncol. 26, 721–728 (2008)

    Article  Google Scholar 

  22. S. Paik, G. Tang, S. Shak, C. Kim, J. Baker, W. Kim, M. Cronin, F.L. Baehner, D. Watson, J. Bryant, J.P. Costantino, C.E. Jr Geyer, D.L. Wickerham, N. Wolmark, J. Clin. Oncol. 24, 3726–3734 (2006)

    Article  Google Scholar 

  23. D.C. Allred, J.M. Harvey, M. Berardo, G.M. Clark, Mod. Pathol. 11, 155–168 (1998)

    Google Scholar 

  24. A. Naressi, C. Couturier, J.M. Devos, M. Janssen, C. Mangeat, R. de Beer, D. Graveron-Demilly, MAGMA 12, 141–152 (2001)

    Article  Google Scholar 

  25. T.F. Bathen, B. Geurts, B. Sitter, H.E. Fjøsne, S. Lundgren, L.M. Buydens, I.S. Gribbestad, G. Postma, G.F. Giskeødegård, PLoS One 8, e61578 (2013). doi:10.1371/journal.pone.0061578

    Article  ADS  Google Scholar 

  26. S.A. Moestue, E. Borgan, E.M. Huuse, E.M. Lindholm, B. Sitter, A.L. Børresen-Dale, O. Engebraaten, G.M. Maelandsmo, I.S. Gribbestad, BMC Cancer 10, 433 (2010)

    Article  Google Scholar 

  27. B. Sitter, T.F. Bathen, T.E. Singstad, H.E. Fjøsne, S. Lundgren, J. Halgunset, I.S. Gribbestad, NMR Biomed. 23, 424–431 (2010)

    Google Scholar 

  28. O. Warburg, Science 123, 309–314 (1956)

    Article  ADS  Google Scholar 

  29. D. Rivenzon-Segal, S. Boldin-Adamsky, D. Seger, R. Seger, H. Degani, Int. J. Cancer 107, 177–182 (2003)

    Article  Google Scholar 

  30. S. Walenta, M. Wetterling, M. Lehrke, G. Schwickert, K. Sundfør, E.K. Rofstad, W. Mueller-Klieser, Cancer Res. 60, 916–921 (2000)

    Google Scholar 

  31. H. Yokota, J. Guo, M. Matoba, K. Higashi, H. Tonami, Y. Nagao, J. Magn. Reson. Imaging 25, 992–999 (2007)

    Article  Google Scholar 

  32. D.M. Brizel, T. Schroeder, R.L. Scher, S. Walenta, R.W. Clough, M.W. Dewhirst, W. Mueller-Klieser, Int. J. Radiat. Oncol. Biol. Phys. 51, 349–353 (2001)

    Article  Google Scholar 

  33. R. Katz-Brull, D. Seger, D. Rivenson-Segal, E. Rushkin, H. Degani, Cancer Res. 62, 1966–1970 (2002)

    Google Scholar 

  34. C.M. Perou, T. Sørlie, M.B. Eisen, M. van de Rijn, S.S. Jeffrey, C.A. Rees, J.R. Pollack, D.T. Ross, H. Johnsen, L.A. Akslen, O. Fluge, A. Pergamenschikov, C. Williams, S.X. Zhu, P.E. Lønning, A.L. Børresen-Dale, P.O. Brown, D. Botstein, Nature 406, 747–752 (2000)

    Article  ADS  Google Scholar 

Download references

Acknowledgments

The biospecimens and data used in this study were provided by the Asan Bio-Resource Center, Korea Biobank Network (2011-7(36)).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hee Jung Shin.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Shin, H.J., Kim, S., Baek, HM. et al. Prediction of Indolent Breast Cancer with Favorable Prognostic Factors by Metabolic Profiling Using In Vivo and Ex Vivo MR Metabolomics. Appl Magn Reson 47, 159–174 (2016). https://doi.org/10.1007/s00723-015-0755-3

Download citation

  • Received:

  • Revised:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00723-015-0755-3

Keywords

Navigation